236 related articles for article (PubMed ID: 15704203)
1. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
Deterding R; Retsch-Bogart G; Milgram L; Gibson R; Daines C; Zeitlin PL; Milla C; Marshall B; Lavange L; Engels J; Mathews D; Gorden J; Schaberg A; Williams J; Ramsey B;
Pediatr Pulmonol; 2005 Apr; 39(4):339-48. PubMed ID: 15704203
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.
Deterding RR; Lavange LM; Engels JM; Mathews DW; Coquillette SJ; Brody AS; Millard SP; Ramsey BW;
Am J Respir Crit Care Med; 2007 Aug; 176(4):362-9. PubMed ID: 17446337
[TBL] [Abstract][Full Text] [Related]
3. Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.
Kellerman D; Rossi Mospan A; Engels J; Schaberg A; Gorden J; Smiley L
Pulm Pharmacol Ther; 2008 Aug; 21(4):600-7. PubMed ID: 18276176
[TBL] [Abstract][Full Text] [Related]
4. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
Accurso FJ; Moss RB; Wilmott RW; Anbar RD; Schaberg AE; Durham TA; Ramsey BW;
Am J Respir Crit Care Med; 2011 Mar; 183(5):627-34. PubMed ID: 21169471
[TBL] [Abstract][Full Text] [Related]
5. Long term effects of denufosol tetrasodium in patients with cystic fibrosis.
Ratjen F; Durham T; Navratil T; Schaberg A; Accurso FJ; Wainwright C; Barnes M; Moss RB;
J Cyst Fibros; 2012 Dec; 11(6):539-49. PubMed ID: 22682898
[TBL] [Abstract][Full Text] [Related]
6. Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trials.
Sucharew H; Goss CH; Millard SP; Ramsey BW;
Contemp Clin Trials; 2006 Dec; 27(6):561-70. PubMed ID: 16875884
[TBL] [Abstract][Full Text] [Related]
7. Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis.
Goss CH; McKone EF; Mathews D; Kerr D; Wanger JS; Millard SP;
J Cyst Fibros; 2008 Mar; 7(2):147-53. PubMed ID: 17728193
[TBL] [Abstract][Full Text] [Related]
8. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.
Murphy TD; Anbar RD; Lester LA; Nasr SZ; Nickerson B; VanDevanter DR; Colin AA
Pediatr Pulmonol; 2004 Oct; 38(4):314-20. PubMed ID: 15334509
[TBL] [Abstract][Full Text] [Related]
9. Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease.
Kellerman D; Evans R; Mathews D; Shaffer C
Adv Drug Deliv Rev; 2002 Dec; 54(11):1463-74. PubMed ID: 12458155
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
Yerxa BR; Sabater JR; Davis CW; Stutts MJ; Lang-Furr M; Picher M; Jones AC; Cowlen M; Dougherty R; Boyer J; Abraham WM; Boucher RC
J Pharmacol Exp Ther; 2002 Sep; 302(3):871-80. PubMed ID: 12183642
[TBL] [Abstract][Full Text] [Related]
11. Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study.
Noone PG; Hamblett N; Accurso F; Aitken ML; Boyle M; Dovey M; Gibson R; Johnson C; Kellerman D; Konstan MW; Milgram L; Mundahl J; Retsch-Bogort G; Rodman D; Williams-Warren J; Wilmott RW; Zeitlin P; Ramsey B;
Pediatr Pulmonol; 2001 Aug; 32(2):122-8. PubMed ID: 11477729
[TBL] [Abstract][Full Text] [Related]
12. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
15. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
16. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
Retsch-Bogart GZ; Burns JL; Otto KL; Liou TG; McCoy K; Oermann C; Gibson RL;
Pediatr Pulmonol; 2008 Jan; 43(1):47-58. PubMed ID: 18041081
[TBL] [Abstract][Full Text] [Related]
17. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
18. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
Lands LC; Milner R; Cantin AM; Manson D; Corey M
J Pediatr; 2007 Sep; 151(3):249-54. PubMed ID: 17719932
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
